Drug information provider Elsevier / Gold Standard, US, has announced that Holliston, Massachusetts-based pharmacy chain Eaton Apothecary has purchased the new Predictive Acquisition Cost (PAC), developed by Glass Box Analytics and exclusively sold by Elsevier / Gold Standard.
Introduced earlier this year, PAC is a new drug price type that more closely tracks true acquisition cost. PAC employs predictive analytics techniques to estimate acquisition cost considering various factors, including MAC benchmarks, published price lists, existing price benchmarks, drug dispensing metrics, supply-demand measures, and survey-based acquisition costs. Independent tests show that PAC tracks drug acquisition cost with sufficient accuracy to support pricing activity.
Eaton Apothecary has 16 locations, including traditional retail pharmacies and those focused on home delivery and specialised care. As a classic community-centered pharmacy, Eaton Apothecary prides itself for its commendable one-on-one service with patients. With a reputation in the industry as an early-adopter of new, enhanced technologies and marketplace trends, Eaton Apothecary selected PAC, adding to the company’s competitive edge.
The pharmacy chain plans to utilise PAC for reimbursement analysis, wholesaler request for proposal processes with standards for deviations from the PAC price type, and as a cash pricing base.
